Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (821-830 of 903) with videos related to

Pageof 91
Sort By:
Haematologica|July 29, 2017
Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trialsJennifer R Brown, Javid Moslehi, Susan O'Brien, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Expression and prognostic impact of lncRNAs in acute myeloid leukemiaRamiro Garzon, Stefano Volinia, Dimitrios Papaioannou, et al.
JAMA Oncology|February 2, 2023
Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated CardiotoxicityBenjamin Buck, Aaron P Chum, Mitkumar Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell CarcinomaElizabeth L McMichael, Brooke Benner, Lakhvir S Atwal, et al.
Blood|May 29, 2014
Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemiaRainer Claus, David M Lucas, Amy S Ruppert, et al.
Cell|June 2, 2007
Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemiaAparna Raval, Stephan M Tanner, John C Byrd, et al.
JAMA Network Open|June 23, 2025
Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid LeukemiaRichard J Marrero, Vivek M Shastri, Deedra Nicolet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid LeukemiaChristopher J Walker, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, et al.
Blood|October 27, 2012
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemiaChristopher J Hickey, Sebastian Schwind, Hanna S Radomska, et al.
Nature Communications|November 4, 2021
Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemiaJanek S Walker, Zachary A Hing, Steven Sher, et al.
Pageof 91

Showing results (821-830 of 903) with videos related to

Sort By:
Pageof 91
Haematologica|July 29, 2017
Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trialsJennifer R Brown, Javid Moslehi, Susan O'Brien, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2014
Expression and prognostic impact of lncRNAs in acute myeloid leukemiaRamiro Garzon, Stefano Volinia, Dimitrios Papaioannou, et al.
JAMA Oncology|February 2, 2023
Cardiovascular Magnetic Resonance Imaging in Patients With Ibrutinib-Associated CardiotoxicityBenjamin Buck, Aaron P Chum, Mitkumar Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell CarcinomaElizabeth L McMichael, Brooke Benner, Lakhvir S Atwal, et al.
Blood|May 29, 2014
Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemiaRainer Claus, David M Lucas, Amy S Ruppert, et al.
Cell|June 2, 2007
Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemiaAparna Raval, Stephan M Tanner, John C Byrd, et al.
JAMA Network Open|June 23, 2025
Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid LeukemiaRichard J Marrero, Vivek M Shastri, Deedra Nicolet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 4, 2019
Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid LeukemiaChristopher J Walker, Jessica Kohlschmidt, Ann-Kathrin Eisfeld, et al.
Blood|October 27, 2012
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemiaChristopher J Hickey, Sebastian Schwind, Hanna S Radomska, et al.
Nature Communications|November 4, 2021
Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemiaJanek S Walker, Zachary A Hing, Steven Sher, et al.
Pageof 91